- 3 updates
The MHRA wrote a letter to doctors on January 22 which stated that "there is no need for anyone who has been using a combined hormonal contraceptive without any problems to stop taking it on the basis of this review".
The MHRA added: "Combined hormonal contraceptives are highly effective in preventing unwanted pregnancy. They offer substantial benefits and these far outweigh the small risk of serious side effects."
Britain's drug watchdog, the Medicines and Healthcare Products Regulatory Agency (MHRA) has ordered UK doctors to pay "careful consideration" to individuals' risk factors before prescribing them the combined hormonal contraceptives.
History of deep vein thrombosis or very high blood pressure are among the conditions that would prevent a doctor recommending the drugs.
This comes after a review by the European Medicines Agency which found that the packaging of the pills should be updated to ensure that women are made aware of the risks of blood clots.
Women who use the UK's most popular contraceptive pills are being warned they risk potentially life-threatening blood clots.
All GPs have been ordered to warn patients that they are almost twice as likely to develop blood clots if they take some of the most popular birth-control tablets, including Yasmin, Femodene and Marvelon, compared with older products.
According to the Mail on Sunday the so-called third generation pills caused 14 deaths a year in France.